2016 annual financial data
Tempest Therapeutics 2016 Operating cash flow margin
Direct answer
Operating cash flow margin was -9,453.91%.
Operating income was -81,012,000 USD and net income was -82,260,000 USD.
Operating cash flow was -61,734,000 USD.
Get free Tempest Therapeutics email updates.
Bullstory sends one daily email when new analysis or important company news is available.
Verified data
- Revenue
- 653,000 USD
- Operating income
- -81,012,000 USD
- Net income
- -82,260,000 USD
- Operating cash flow
- -61,734,000 USD